The decision was announced just days before the Conference on Retroviruses and Opportunistic Infections was to take place.
A generic form of the HIV prevention drug from Teva Pharmaceuticals will come earlier than anticipated — but activists are calling for greater access.
An antibiotic commonly prescribed to treat an HIV-related illness might cause coronary problems years later.
Shigella can be especially serious in HIV-positive people with a low CD4 count.
The infections are traumatic, deadly, and avoidable.
Participants who took efavirenz were eleven times more likely to switch up their drug regimen.
Government limits on research hinder patient relief.